000 01579 a2200445 4500
005 20250518005908.0
264 0 _c20190703
008 201907s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-18-1341
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHong, David S
245 0 0 _aPhase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cApr 2019
300 _a2403-2413 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aHumans
650 0 4 _aMaximum Tolerated Dose
650 0 4 _aNeoplasms
650 0 4 _aProtein Kinase Inhibitors
650 0 4 _aPyridones
650 0 4 _aTreatment Outcome
650 0 4 _aTriazoles
700 1 _aLoRusso, Patricia
700 1 _aHamid, Omid
700 1 _aJanku, Filip
700 1 _aKittaneh, Muaiad
700 1 _aCatenacci, Daniel V T
700 1 _aChan, Emily
700 1 _aBekaii-Saab, Tanios
700 1 _aGadgeel, Shirish M
700 1 _aLoberg, Robert D
700 1 _aAmore, Benny M
700 1 _aHwang, Yuying C
700 1 _aTang, Rui
700 1 _aNgarmchamnanrith, Gataree
700 1 _aKwak, Eunice L
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 25
_gno. 8
_gp. 2403-2413
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-18-1341
_zAvailable from publisher's website
999 _c29040513
_d29040513